newsfilter
← Latest News
Business Wire·

Know Labs Provides 2022 Outlook, Outlines Preparations for Pre-Submission Meeting with FDA

Know Labs, Inc. (OTCQB:KNWN), an emerging leader in non-invasive medical diagnostics, today provided an update on its outlook for 2022, as the company executes its plan to bring the first FDA-cleared non-invasive glucose monitoring devices to market.